Risk of post colonoscopy colorectal cancer according to physician adenoma detection rates

##plugins.themes.academic_pro.article.main##

Sanjeevani Tomar
Ernesto Robalino Gonzaga MD2
Mariam Naveed, MD2
Aasma Shaukat, MD, MPH3
Rajesh N. Keswani, MD, MS4

Abstract

Colonoscopies, which enable detection and removal of pre-cancerous polyps, are an effective method to reduce the incidence of and mortality associated with colorectal cancer. Adenoma detection rate (ADR) is validated for measuring quality of colonoscopy. Here we summarize the @GIJournal discussion held on July 3, 2022, during which we discussed the article by Schottinger et al. titled Association of physician adenoma detection rates with postcolonoscopy colorectal cancer (JAMA 2022; 327:2114–2122)1. The session was moderated by Dr. Mariam Naveed (MN [@MN_GIMD]) and the key findings were critically reviewed by Dr. Aasma Shaukat (AS [@AasmaShaukatMD]) and Dr. Rajesh N. Keswani (RK [@RKeswaniMD]).

##plugins.themes.academic_pro.article.details##

How to Cite
Tomar, S., Ernesto Robalino Gonzaga MD2, Mariam Naveed, MD2, Aasma Shaukat, MD, MPH3, & Rajesh N. Keswani, MD, MS4. (2022). Risk of post colonoscopy colorectal cancer according to physician adenoma detection rates. @Gijournal, 2(1). https://doi.org/10.52697/gijournal.v2i1.37

Most read articles by the same author(s)